$ABBV

$262.44▲ +0.3% YTD

6 SEC 13D/G filings tracked · Last updated Sep 3, 2026

Filing History

CP $262.44▲ +0.3%Sep 3, 2026 · ThinkSabio Blog

$ABBV - AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progressio…

News

ABBV ▲ +0.3% - AbbVie Inc.

CP $262.44▲ +0.3%Sep 3, 2026 · ThinkSabio Blog

$ABBV APGE - AbbVie Completes Acquisition of Apogee Therapeutics…

News

ABBV ▲ +0.0% - AbbVie Inc.

CP $261.72▲ +0.0%Sep 3, 2026 · ThinkSabio Blog

$ABBV - AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference…

News

ABBV ▲ +0.8% - AbbVie Inc.

CP $261.90▲ +0.8%Sep 2, 2026 · ThinkSabio Blog

$ABBV - Allergan Aesthetics Unveils the Layered Beauty Report, Advancing the Global Conversation Around Aesthetic Care…

News

ABBV ▲ +0.5% - AbbVie Inc.

CP $258.02▲ +0.5%Sep 1, 2026 · ThinkSabio Blog

$ABBV - SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings…

News

ABBV ▼ -0.2% - AbbVie Inc.

CP $255.08▲ -0.2%Aug 31, 2026 · ThinkSabio Blog

$ABBV - AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference…